🌎 Pinnacle West Capital Upgraded, Procter & Gamble Upgraded, Duolingo Initiated and more…
RJ Hamster
Ratings changes for Kingsoft Cloud, Xcel Energy, Amylyx Pharmaceuticals, Canadian Solar, Netflix, OptiNose, Brainstorm Cell Therapeutics and more…Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
The Wall Street Journal reports that this medical breakthrough is “Transforming Medicine.” One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today’s price.
CFO Ruth Porat sold 48,077 shares of the stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $137.22, for a total value of $6,597,125.94. Following the completion of the sale, the chief financial officer now owns 1,777,106 shares of the company’s stock, valued at $243,854,485.32. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Alphabet saw some unusual options trading activity on Friday. Traders acquired 406,853 call options on the stock. This represents an increase of 31% compared to the average volume of 311,090 call options.
Algonquin Power & Utilities (NYSE:AQN) was upgraded by analysts at Desjardins from a “sell” rating to a “hold” rating.The current price is $6.46.
Bilibili (NASDAQ:BILI) was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating. They now have a $11.00 price target on the stock, up previously from $10.00. This represents a 13.7% downside from the current price of $12.74.
Choice Hotels International (NYSE:CHH) was upgraded by analysts at Jefferies Financial Group Inc. from an “underperform” rating to a “buy” rating. They now have a $156.00 price target on the stock, up previously from $96.00. This represents a 23.2% upside from the current price of $126.65.
DoubleVerify (NYSE:DV) was upgraded by analysts at Macquarie from a “neutral” rating to an “outperform” rating. They now have a $40.00 price target on the stock. This represents a 24.2% upside from the current price of $32.20.
Foot Locker (NYSE:FL) was upgraded by analysts at UBS Group AG from a “sell” rating to a “neutral” rating. They now have a $23.00 price target on the stock, up previously from $12.00. This represents a 5.7% downside from the current price of $24.39.
Freshpet (NASDAQ:FRPT) was upgraded by analysts at Truist Financial Co. from a “hold” rating to a “buy” rating. They now have a $135.00 price target on the stock, up previously from $120.00. This represents a 24.5% upside from the current price of $108.46.
Kingsoft Cloud (NASDAQ:KC) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating.The current price is $3.57.
Lions Gate Entertainment (NYSE:LGF.A) was upgraded by analysts at Barrington Research from a “market perform” rating to an “outperform” rating. They now have a $12.00 price target on the stock. This represents a 30.9% upside from the current price of $9.17.
Lions Gate Entertainment (NYSE:LGF-A) was upgraded by analysts at Barrington Research from a “market perform” rating to an “outperform” rating. They now have a $12.00 price target on the stock. This represents a 30.9% upside from the current price of $9.17.
PDD (NASDAQ:PDD) was upgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to a “buy” rating. They now have a $157.00 price target on the stock, up previously from $117.00. This represents a 38.1% upside from the current price of $113.68.
Procter & Gamble (NYSE:PG) was upgraded by analysts at Truist Financial Co. from a “hold” rating to a “buy” rating. They now have a $175.00 price target on the stock, up previously from $160.00. This represents a 8.5% upside from the current price of $161.35.
Pinnacle West Capital (NYSE:PNW) was upgraded by analysts at UBS Group AG from a “sell” rating to a “neutral” rating. They now have a $71.00 price target on the stock, up previously from $68.00. This represents a 1.1% downside from the current price of $71.79.
STAAR Surgical (NASDAQ:STAA) was upgraded by analysts at Stifel Nicolaus from a “hold” rating to a “buy” rating. They now have a $50.00 price target on the stock, up previously from $30.00. This represents a 27.9% upside from the current price of $39.10.
Xcel Energy (NASDAQ:XEL) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating. They now have a $58.00 price target on the stock. This represents a 10.2% upside from the current price of $52.62.
Xcel Energy (NASDAQ:XEL) was upgraded by analysts at Barclays PLC from an “equal weight” rating to an “overweight” rating. They now have a $54.00 price target on the stock, down previously from $61.00. This represents a 2.6% upside from the current price of $52.62.
Hidden In Plain Sight–The Secret To Earning More! (ad)
Hi, this is 10 time trading champion Chuck Hughes and for a long time even I was missing out on the strategy that took my account to a whole new level… In my new guide, “Hidden Income Strategy”, I’ll reveal exactly how you could use this unique strategy to earn more–starting now!
American Electric Power (NASDAQ:AEP) was downgraded by analysts at UBS Group AG from a “neutral” rating to a “sell” rating. They now have a $83.00 price target on the stock, down previously from $86.00. This represents a 0.4% downside from the current price of $83.36.
Amylyx Pharmaceuticals (NASDAQ:AMLX) was downgraded by analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating.The current price is $3.42.
Amylyx Pharmaceuticals (NASDAQ:AMLX) was downgraded by analysts at SVB Leerink LLC from an “outperform” rating to a “market perform” rating.The current price is $3.42.
Bilibili (NASDAQ:BILI) was downgraded by analysts at Citigroup Inc. from a “buy” rating to a “neutral” rating. They now have a $12.50 price target on the stock, down previously from $18.00. This represents a 1.9% downside from the current price of $12.74.
Dominion Energy (NYSE:D) was downgraded by analysts at BMO Capital Markets from an “outperform” rating to a “market perform” rating. They now have a $49.00 price target on the stock. This represents a 3.0% upside from the current price of $47.57.
Hyatt Hotels (NYSE:H) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating. They now have a $156.00 price target on the stock, up previously from $149.00. This represents a 1.0% upside from the current price of $154.38.
Light & Wonder (NASDAQ:LNW) was downgraded by analysts at Redburn Atlantic from a “buy” rating to a “neutral” rating. They now have a $110.00 price target on the stock, up previously from $105.00. This represents a 9.9% upside from the current price of $100.06.
Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating. They now have a $18.00 price target on the stock, down previously from $20.00. This represents a 21.3% upside from the current price of $14.84.
PDD (NASDAQ:PDD) was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “neutral” rating. They now have a $136.00 price target on the stock. This represents a 19.6% upside from the current price of $113.68.
Foreign Affairs reports, “China is Now in a Prewar Tempo of Political and Military Preparations.” China has one goal: take control of Taiwan, and an invasion could happen any day. I’ve identified 5 investments I believe are in immediate danger. But you can get out of them now – before it’s too late.
ArcBest (NASDAQ:ARCB) is now covered by analysts at JPMorgan Chase & Co.. They set an “overweight” rating and a $168.00 price target on the stock. This represents a 25.1% upside from the current price of $134.26.
Canadian Solar (NASDAQ:CSIQ) is now covered by analysts at Daiwa Capital Markets. They set a “neutral” rating and a $21.00 price target on the stock. This represents a 0.1% upside from the current price of $20.98.
Duolingo (NASDAQ:DUOL) is now covered by analysts at JPMorgan Chase & Co.. They set an “overweight” rating and a $270.00 price target on the stock. This represents a 21.7% upside from the current price of $221.79.
Erasca (NASDAQ:ERAS) is now covered by analysts at Capital One Financial Co.. They set an “overweight” rating and a $8.00 price target on the stock. This represents a 254.0% upside from the current price of $2.26.
Hubbell (NYSE:HUBB) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “hold” rating and a $427.00 price target on the stock. This represents a 12.2% upside from the current price of $380.66.
Joint Stock Company Kaspi.kz (NASDAQ:KSPI) is now covered by analysts at JPMorgan Chase & Co.. They set an “overweight” rating and a $159.00 price target on the stock. This represents a 48.7% upside from the current price of $106.90.
Lamb Weston (NYSE:LW) is now covered by analysts at BNP Paribas. They set an “outperform” rating and a $128.00 price target on the stock. This represents a 25.7% upside from the current price of $101.86.
nVent Electric (NYSE:NVT) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $83.00 price target on the stock. This represents a 22.1% upside from the current price of $67.98.
Old Dominion Freight Line (NASDAQ:ODFL) is now covered by analysts at JPMorgan Chase & Co.. They set a “neutral” rating and a $465.00 price target on the stock. This represents a 8.2% upside from the current price of $429.61.
OptiNose (NASDAQ:OPTN) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $5.00 price target on the stock. This represents a 177.8% upside from the current price of $1.80.
PHINIA (NYSE:PHIN) is now covered by analysts at Morgan Stanley. They set an “overweight” rating and a $50.00 price target on the stock. This represents a 39.1% upside from the current price of $35.94.
REGENXBIO (NASDAQ:RGNX) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $36.00 price target on the stock. This represents a 54.8% upside from the current price of $23.25.
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Piper Sandler. They set an “overweight” rating and a $43.00 price target on the stock. This represents a 28.4% upside from the current price of $33.48.
Saia (NASDAQ:SAIA) is now covered by analysts at JPMorgan Chase & Co.. They set an “overweight” rating and a $676.00 price target on the stock. This represents a 18.2% upside from the current price of $572.05.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
UPGRADE NOW
Manage Your Watchlist
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO
Join Our Facebook Group
Join MarketBeat’s free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that’s you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
